Actualités

Oscar Health (OSCR) is back in focus after reporting second quarter 2026 results that swung from a loss to net income of $361.81 million and raising full year earnings guidance. See our latest analysis for Oscar Health. Oscar Health shares have been volatile around the earnings release, with an 11.9% drop reported after the outlook update. The stock still shows a 118.84% year to date share price return and a 109.46% 1 year total shareholder return, suggesting momentum remains strong despite...

Why Iovance Biotherapeutics stock is back in focus after Q2 earnings Iovance Biotherapeutics (IOVA) is back on investor radars after its second quarter 2026 earnings. The company reported higher revenue and a reduced net loss, and it reaffirmed full year revenue guidance. The quarter was driven by Amtagvi and Proleukin sales, and by progress across Iovance Biotherapeutics pipeline programs, including new regulatory approvals and Fast Track designations for lifileucel in certain soft tissue...

The rapid growth days of each company are probably over, but each stock remains an excellent choice for income investors.

AI-driven efficiencies are an underappreciated catalyst for the fintech company.

QXO earnings and recent performance QXO (QXO) reported second quarter 2026 results on August 13, with sales of US$3.25b and a net loss of US$55m. Six month sales reached US$4.98b, with a net loss of US$282m. See our latest analysis for QXO. QXO's share price has come under pressure despite the recent earnings report and the completion of the TopBuild acquisition, with the stock down 10% over the past week and recording a 26% year to date share price decline and a 5 year total shareholder...

Unity’s second quarter results were marked by robust revenue growth and significant margin improvement, triggering a notable positive market response. Management cited the rapid adoption of its Vector AI-powered ad platform and a suite of product enhancements as primary drivers of performance. CEO Matthew Bromberg emphasized the impact of integrating runtime data and noted, “Our astounding performance is fueling a 63% year-over-year increase in our Strategic Grow business.” The company’s renewed

Despite a 54% revenue decline, Sidus Space strengthens its balance sheet with a major capital raise and advances key technology milestones toward TRL 9.

Despite logistical challenges and stagnant top-line, the company leverages robust domestic sales, a thriving frozen segment, and new pectin production to drive future growth.

CEO Bill Ackman outlines plans for investment-grade debt, a new venture vehicle, and potential upside from Fannie Mae and Freddie Mac to drive long-term shareholder value.

Core revenue surges 103% year-over-year to $209.9 million, with RPO reaching $25.4 billion and new AWS and AMD collaborations expanding market reach.

Gemini Space Station Inc (GEMI) reports record services revenue and cost cuts, yet faces headwinds from a 66% drop in spot trading volume and a $20.1 million fraud-related provision.

nCino has had an impressive run over the past six months as its shares have beaten the S&P 500 by 7.4%. The stock now trades at $19.16, marking a 20.9% gain. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.

Moby summary of Super League Enterprise, Inc.'s Q2 2026 earnings call

Moby summary of PAVmed Inc.'s Q2 2026 earnings call

IonQ, Quantinuum, and other notable names in the quantum sector have reported earnings, which broadly showed that traction continues to grow.

Moby summary of Creative Media & Community Trust Corporation's Q2 2026 earnings call

Moby summary of Digi Power X Inc.'s Q2 2026 earnings call

Moby summary of Americas Gold and Silver Corporation's Q2 2026 earnings call

Moby summary of Edible Garden AG Incorporated's Q2 2026 earnings call

Sandisk's (SNDK) long-term targets suggest Wedbush Securities' fiscal 2028 estimates understate the

The earnings outlook improved, but the multiple just fell

SanDisk, Pagaya, NeoVolta and Aeromexico offer 35%+ upside potential after strong Q2 results, with growth catalysts across key industries.

UBS Raises the Stakes for Nvidia: $95 Billion Revenue Beat Seen Ahead

Dell Technologies stock could have more room to run—even after this year’s meteoric rise—as artificial intelligence hardware demand remains resilient. Wells Fargo analyst Aaron Rakers raised his price target on Dell to $545 from $505 on Friday, which implies a 10% increase from the stock’s last closing price of $494.51. Dell’s “server results and outlook present continued upside,” Rakers wrote in a research note.

Three Pfizer insiders executed transactions directly on the heels of the drugmaker’s second-quarter earnings report.

The crypto miner's total cost to mine one bitcoin reached $90,631, topping the $71,667 average production value during the quarter

Moby summary of CSP Inc.'s Q3 2026 earnings call

Moby summary of Acurx Pharmaceuticals, Inc.'s Q2 2026 earnings call

GLNG's second-quarter 2026 earnings and revenues improve year over year.

Yahoo Finance Market and Data Editor Jared Blikre and Senior Business Reporter Ines Ferre join the Executive Editor Brian Sozzi on the Opening Bid panel to preview Nvidia's (NVDA) upcoming earnings and assess what could be next for stock in the weeks ahead.